Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):e108-e110. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.012. Epub 2017 Mar 30.

Abstract

We present an autopsy case of repetitive stroke due to tumor emboli, indistinguishable from thromboembolism with a hypercoagulable state in its clinical course. A 72-year-old man diagnosed with stage IVA oropharyngeal squamous cell carcinoma received chemoradiotherapy. Follow-up imaging revealed mediastinal lymph nodes and pulmonary metastasis. One year later, the patient experienced right arm weakness, and brain magnetic resonance imaging showed acute ischemic lesions in multiple vascular territories. He was diagnosed with paradoxical cerebral embolism due to cancer-associated venous thrombosis and treated with rivaroxaban. However, newly developed cerebral infarcts were confirmed 1 month later. Then, rivaroxaban treatment was switched to subcutaneous unfractionated heparin injection. He was admitted again for stroke recurrence and died of respiratory failure 8 days after admission. Autopsy demonstrated pulmonary metastasis invading the veins and tumor emboli in the culprit cerebral arteries. D-dimer was kept constant at a slightly higher level, ranging from 1 to 3 µg/mL during the course of recurrence. We should consider tumor embolism in the differential diagnosis of recurrent stroke along with pulmonary tumor and resistance to heparin preparations with unchanged D-dimer levels.

Keywords: Recurrent stroke; cancer-related stroke; pulmonary metastases; tumor embolism.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use
  • Autopsy
  • Biomarkers / blood
  • Biopsy
  • Carcinoma, Squamous Cell / complications
  • Carcinoma, Squamous Cell / diagnostic imaging
  • Carcinoma, Squamous Cell / secondary*
  • Carcinoma, Squamous Cell / therapy
  • Diffusion Magnetic Resonance Imaging
  • Fatal Outcome
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Head and Neck Neoplasms / complications
  • Head and Neck Neoplasms / pathology*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Intracranial Embolism / diagnosis
  • Intracranial Embolism / drug therapy
  • Intracranial Embolism / etiology*
  • Lung Neoplasms / complications
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / therapy
  • Lymphatic Metastasis
  • Male
  • Neoplasm Staging
  • Neoplastic Cells, Circulating / pathology*
  • Oropharyngeal Neoplasms / complications
  • Oropharyngeal Neoplasms / pathology*
  • Oropharyngeal Neoplasms / therapy
  • Recurrence
  • Respiratory Insufficiency / etiology
  • Squamous Cell Carcinoma of Head and Neck
  • Stroke / diagnosis
  • Stroke / drug therapy
  • Stroke / etiology*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D